REASONS FOR NON-USE OF RECOVERED KIDNEYS: THE EFFECT OF DONOR GLOMERULOSCLEROSIS AND CREATININE CLEARANCE ON GRAFT SURVIVAL

Background. In 2000, the United Network for Organ Sharing/Organ Procurement and Transplantation Network Registry reported 540 recovered kidneys were discarded because of biopsy results, and 210 were discarded because of poor organ function. We compared the percentage of glomerulosclerosis (GS) and creatinine clearance (CrCl) of both discarded and transplanted cadaveric kidneys and examined their effect on graft survival and function. Methods. The cohort consisted of all cadaveric kidneys (n= 3,444) with reported biopsy results between October 25, 1999 and December 31, 2001. Graft survival was calculated by univariate and multivariate models. Results. Fifty-one percent of discarded kidneys had GS of less than 20%, 27% had a CrCl greater than 80 mL/min, and 15% (129 kidneys) had both GS less than 20% and a CrCl of greater than 80 mL/min. Univariate analyses of kidneys with less than or equal to 20% GS revealed no difference in 1-year graft survival when the CrCl was greater than or less than or equal to 80 mL/min. When GS was greater than 20%, 1-year graft survival of kidneys with a CrCl of greater than 80 mL/min was significantly greater than that of kidneys with a CrCl of less than or equal to 80 mL/min. Multivariate results showed no significant difference in relative risk of graft loss with GS greater than 20% versus less than or equal to 20% when the CrCl was either 50 or 80 mL/min. With both GS less than or equal to 20% and greater than 20%, serum creatinine at 1 year was significantly lower in kidneys with CrCl greater 80 mL/min. Conclusions. Calculated donor CrCl does, and percentage GS on donor kidney biopsies does not, correlate well with 1-year graft survival and function, and percentage GS should not be used as the sole criterion for discarding recovered cadaveric kidneys.

[1]  J Karpinski,et al.  Outcome of kidney transplantation from high-risk donors is determined by both structure and function. , 1999, Transplantation.

[2]  R. Wolfe,et al.  Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. , 2001, Journal of the American Society of Nephrology : JASN.

[3]  C. Kjellstrand,et al.  On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  A. Demetris,et al.  Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. , 2000, Transplantation.

[5]  T. Larson,et al.  Donor Scoring System for Cadaveric Renal Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  C. Mullins,et al.  The economic impact of laparoscopic living-donor nephrectomy on kidney transplantation , 2003, Transplantation.

[7]  A. Gaber,et al.  GLOMERULOSCLEROSIS AS A DETERMINANT OF POSTTRANSPLANT FUNCTION OF OLDER DONOR RENAL ALLOGRAFTS , 1995, Transplantation.

[8]  J. Carter,et al.  EVALUATION OF THE OLDER CADAVERIC KIDNEY DONOR: THE IMPACT OF DONOR HYPERTENSION AND CREATININE CLEARANCE ON GRAFT PERFORMANCE AND SURVIVAL12 , 2000, Transplantation.

[9]  S. Hariharan,et al.  Risk factors for renal allograft survival from older cadaver donors. , 1998, Transplantation.

[10]  C M Smith,et al.  Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. , 1998, JAMA.

[11]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[12]  J. Gross,et al.  Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  Christopher P. Johnson,et al.  A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation , 2003, Transplantation.

[14]  H. Ekberg,et al.  Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. , 2000, Transplantation.

[15]  B. Zarowitz,et al.  Predictability of creatinine clearance estimates in critically ill patients , 1993, Critical care medicine.